Extraordinary general meeting of Cell ImpactAn extraordinary general meeting of Cell Impact AB (publ) was held on 16 November 2021 whereby the shareholders, inter alia, authorized the board of directors to resolve upon issue of shares, warrants and/or convertibles. The extraordinary general meeting authorized the board of directors to, until the next annual general meeting and within the limits of the articles of association and on one or more occasions and with preferential rights for the shareholders, resolve upon issues of shares, warrants, and/or convertibles. Issues may be made against cash payment, issue in kind and/or set-off, or otherwise be combined with conditions. Issues may in total not entail an increase of the company's share capital by more than 50 percent, calculated on the size of the share capital the first time the authorization is used.
The authorization of the board of directors to resolve upon issue of shares, warrants and/or convertibles shall replace the previous authorization resolved upon by the general meeting on 9 August 2021 and which was registered with the Swedish Companies Registration Office on 13 August 2021.
Due to the COVID-19 pandemic, the extraordinary general meeting was conducted by postal vote, without physical attendance.
For more detailed information on the content of the resolutions, please see the notice convening the extraordinary general meeting and the complete proposals, which are available on the company's website www.cellimpact.com. For more information, please contact:
Pär Teike, CEO, +46 73-024 06 84 or [email protected].
The following documents can be retrieved from beQuoted
Cell Impact PressRelease EN 20211116.pdf About Cell Impact
Cell Impact AB (publ) is a global supplier of advanced flow plates to fuel cell manufacturers. The company has developed and patented a unique method for high-velocity forming, Cell Impact Forming™, which makes it possible to produce flow plates with more advanced designs, which in turn creates more cost and energy-efficient fuel cells compared to conventional forming methods.
The Cell Impact share is listed on Nasdaq First North Growth Market and FNCA Sweden AB is the company's Certified Advisor (CA). Contact info: +46 8-528 00 399 or [email protected].
If you want to open the text in your webbrowser
click here
______________________________________________________
This information was sent by beQuoted
If you want more information, please go to www.beQuoted.com
To change your subscription, please inform [email protected] beQuoted Press är en service till Dig som är intresserad av finansiell information. Med beQuoted Press underlättas företagens finansiella kommunikation till Dig och till nyhetsbyråer, aktieägare, placeringsrådgivare och andra intressenter på aktiemarknaden.
Vi hoppas att Du uppskattar denna service.
| 